引用本文:李福建,宋怀宇,黄定贵.代谢功能障碍相关脂肪变性肝病治疗的研究进展[J].中国临床新医学,2024,17(3):351-354.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 216次   下载 329 本文二维码信息
码上扫一扫!
分享到: 微信 更多
代谢功能障碍相关脂肪变性肝病治疗的研究进展
李福建1,宋怀宇1,黄定贵2
1.广西壮族自治区人民医院(广西医学科学院)消化科,南宁 530021;2.广西壮族自治区人民医院(广西医学科学院)健康体检中心,南宁 530021
摘要:
[摘要] 代谢功能障碍相关脂肪变性肝病(MASLD)是慢性肝病之一,严重危害人类健康。其发病机制复杂,目前尚无特效治疗药物。近年来的研究提出了更多的发病机制及对应的治疗方案。该文对代谢功能障碍相关脂肪变性肝病治疗的研究进展作一综述。
关键词:  代谢功能障碍相关脂肪变性肝病  生活方式管理  药物治疗  手术治疗
DOI:10.3969/j.issn.1674-3806.2024.03.22
分类号:R 575
基金项目:广西医疗卫生适宜技术开发与推广应用项目(编号:S2019080);广西卫生健康委员会自筹经费科研课题(编号:Z-A20230161)
Research progress in the treatment of metabolic dysfunction-associated steatotic liver disease
LI Fujian1, SONG Huaiyu1, HUANG Dinggui2
1.Department of Gastroenterology, the People′s Hospital of Guangxi Zhuang Autonomous Region(Guangxi Academy of Medical Sciences), Nanning 530021,China; 2.Health Examination Center, the People′s Hospital of Guangxi Zhuang Autonomous Region(Guangxi Academy of Medical Sciences), Nanning 530021, China
Abstract:
[Abstract] Metabolic dysfunction-associated steatotic liver disease(MASLD) is one of the chronic liver diseases, which causes a serious hazard to human health. However, the pathogenesis mechanisms of MASLD are complex and no specific drugs are available to treat it at present. In recent years, studies have proposed more pathogenesis mechanisms and their corresponding therapeutic schemes. This paper reviews the research progress in the treatment of MASLD.
Key words:  Metabolic dysfunction-associated steatotic liver disease(MASLD)  Lifestyle management  Medication  Surgical treatment